<DOC>
	<DOCNO>NCT01557257</DOCNO>
	<brief_summary>To characterize single- multiple-dose pharmacokinetics oxycodone follow administration ALO-02 40 Mg Twice Daily , ALO-02 80 Mg Once Daily Oxycontin 40 Mg Twice Daily Healthy Volunteers</brief_summary>
	<brief_title>Pharmacokinetics Study ALO-02 OxyContin</brief_title>
	<detailed_description />
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year , inclusive . Evidence history clinically significant disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>single- multiple-dose pharmacokinetics</keyword>
	<keyword>ALO-02</keyword>
	<keyword>OxyContin</keyword>
</DOC>